MedKoo Cat#: 463357 | Name: Flopropione

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Flopropione is a spasmolytic or antispasmodic agent. It acts as a COMT inhibitor. It is synthetized from phloroglucinol in a Hoesch reaction.

Chemical Structure

Flopropione
Flopropione
CAS#2295-58-1

Theoretical Analysis

MedKoo Cat#: 463357

Name: Flopropione

CAS#: 2295-58-1

Chemical Formula: C9H10O4

Exact Mass: 182.0579

Molecular Weight: 182.18

Elemental Analysis: C, 59.34; H, 5.53; O, 35.13

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Flopropione; Chlonarin; NSC 97909; NSC97909; NSC-97909; Phloropropionone; Supanate;
IUPAC/Chemical Name
1-(2,4,6-trihydroxyphenyl)propan-1-one
InChi Key
PTHLEKANMPKYDB-UHFFFAOYSA-N
InChi Code
InChI=1S/C9H10O4/c1-2-6(11)9-7(12)3-5(10)4-8(9)13/h3-4,10,12-13H,2H2,1H3
SMILES Code
CCC(c1c(O)cc(O)cc1O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 182.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ohgaki K. Efficacy of Naftopidil as a Medical Expulsive Therapy in Japanese Men With Ureteral Stones: A Prospective Randomized Controlled Study. J Clin Med Res. 2019 Jul;11(7):495-500. doi: 10.14740/jocmr3843. Epub 2019 Jun 11. PMID: 31236168; PMCID: PMC6575123. 2: Aso Y, Yoshioka S, Kojima S. Relationship between the crystallization rates of amorphous nifedipine, phenobarbital, and flopropione, and their molecular mobility as measured by their enthalpy relaxation and (1)H NMR relaxation times. J Pharm Sci. 2000 Mar;89(3):408-16. doi: 10.1002/(SICI)1520-6017(200003)89:3<408::AID-JPS11>3.0.CO;2-#. PMID: 10707020. 3: Kohjimoto Y, Hagino K, Ogawa T, Inagaki T, Kitamura S, Nishihata M, Iba A, Matsumura N, Hara I. Naftopidil versus flopropione as medical expulsive therapy for distal ureteral stones: results of a randomized, multicenter, double-blind, controlled trial. World J Urol. 2015 Dec;33(12):2125-9. doi: 10.1007/s00345-015-1556-x. Epub 2015 Apr 14. PMID: 25869815. 4: Kondo A, Shimizu K. [Spanate (flopropione), its clinical evaluation for urolithiasis and effects on ureteral peristalsis and blood pressure in dogs]. Hinyokika Kiyo. 1969 Oct;15(10):748-54. Japanese. PMID: 5390817. 5: Bhugra C, Shmeis R, Krill SL, Pikal MJ. Predictions of onset of crystallization from experimental relaxation times I-correlation of molecular mobility from temperatures above the glass transition to temperatures below the glass transition. Pharm Res. 2006 Oct;23(10):2277-90. doi: 10.1007/s11095-006-9079-1. Epub 2006 Aug 24. PMID: 16933094.